Felip et al. [12] found that ABTL0812 (an anti-cancer drug) inhibited the PI3K/AKT/mTORC1 axis by up-regulating the expression of TRIB3 to sensitize endometrial cancer cells. Here, TRIB3 is linked to cancer.